Titan Pharmaceuticals, Inc. (TTNP) Financials

Stock symbol TTNP is outdated, potentially delisted? Maybe it is available on other exchange?

TTNP Assets vs Liabilities

Date	Assets	Liabilities
Sept. 30, 2023	10.0 million	1.9 million
June 30, 2023	812000	1.8 million
March 31, 2023	2.2 million	2.5 million
Dec. 31, 2022	4.1 million	2.7 million

TTNP Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Sept. 30, 2023	-1.8 million	411000
June 30, 2023	-1.1 million	264000
March 31, 2023	-1.9 million	290000
Dec. 31, 2022	-1.6 million	-91000

TTNP Net Income

No data available :(

TTNP Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Sept. 30, 2023	8.1 million	-	97000
June 30, 2023	105000	-	128000
March 31, 2023	1.1 million	-	158000
Dec. 31, 2022	2.9 million	-	187000

TTNP Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Sept. 30, 2023	15.0 million
June 30, 2023	15.0 million
March 31, 2023	15.0 million
Dec. 31, 2022	13434

TTNP Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Sept. 30, 2023	-	424000	1.6 million	-
June 30, 2023	-	442000	1.2 million	-
March 31, 2023	-	561000	1.2 million	-
Dec. 31, 2022	-	1.4 million	1.3 million	-

TTNP Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Sept. 30, 2023	4000	27000
June 30, 2023	1000	442000
March 31, 2023	98000	43000
Dec. 31, 2022	51000	45000

TTNP

Price: $2.34

52 week price:

2.33

15.15

Earnings Per Share: -2.92 USD

P/E Ratio: -0.80

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 35000

Ebitda: -4.0 million

Market Capitalization: 3.1 million

Links:

TTNP on Yahoo Finance